蛋白酶

CAS号：1009119-64-5

品名：达卡他韦daclatasvir

中文别名：N,N'-[[1,1'-联苯]-4,4'-二基双[1H-咪唑-5,2-二基-(2S)-2,1-吡咯烷二基[(1S)-1-(1-甲基乙基)-2-氧代-2,1-乙烷二基]]]双氨基甲酸C,C'-二甲酯;

英文别名：Carbamicacid,N,​N'-​[[1,​1'-​biphenyl]​-​4,​4'-​diylbis[1H-​imidazole-​5,​2-​diyl-​(2S)​-​2,​1-​pyrrolidinediyl[(1S)​-​1-​(1-​methylethyl)​-​2-​oxo-​2,​1-​ethanediyl]​]​]​bis-​,C,​C'-​dimethylester;N,N'-[[1,1'-Biphenyl]-4,4'-diylbis[1H-imidazole-5,2-diyl-(2S)-2,1-pyrrolidinediyl[(1S)-1-(1-methylethyl)-2-oxo-2,1-ethanediyl]]]biscarbamicacidC,C'-dimethylester;BMS-790052;EBP883;Daclatasvir;

分子式：C40H50N8O6

分子量：738.875

精确质量：738.385

Psa：174.64

UNII号：LI2427F9CI

密度：1.249

简介：Daclatasvir(USAN,formerlyBMS-790052,tradenameDaklinza)isadrugforthetreatmentofhepatitisC(HCV).ItwasdevelopedbyBristol-MyersSquibbandwasapprovedinEuropeon22August2014.DaklinzagaineditsFDAapprovalonJuly24,2015intheUnitedStates;itisapprovedforHepatitisCgenotype3infections.